ORIGINAL RESEARCH article

Front. Pediatr., 07 June 2023

Sec. Pediatric Cardiology

Volume 11 - 2023 | https://doi.org/10.3389/fped.2023.1206032

Prenatal diagnosis and postnatal verification in fetuses with total anomalous pulmonary venous connection

  • 1. Department of Medical Ultrasonics, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China

  • 2. Department of Ultrasound, International Peace Maternity & Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • 3. Department of Pathology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China

  • 4. Department of Obstetrics & Gynecology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China

Article metrics

View details

5

Citations

3,5k

Views

1,1k

Downloads

Abstract

Objective:

To systematically verify the accuracy of a four-step prenatal ultrasonography in diagnosing fetal total anomalous pulmonary venous connection (TAPVC).

Methods:

A total of 62 TAPVC fetuses received prenatal ultrasonography and were confirmed by postnatal echocardiography, surgery, or postabortion autopsy. The suspected TAPVC fetuses were further screened by a four-step prenatal ultrasonography for TAPVC classification, pulmonary venous obstruction, and the associated malformations, and followed postpartum. The sonographic features, clinical data, and prognosis of the TAPVC fetuses were retrospectively analyzed.

Results:

Of the 62 TAPVC fetuses, supracardiac TAPVC was found in 20 cases, intracardiac TAPVC in 12, infracardiac TAPVC in 21, and mixed TAPVC in 9. A total of 30 cases with right atrium isomerism were correctly diagnosed. Of the 11 cases with other intracardiac and extracardiac malformations, 1 case was missed to be diagnosed. Of the 21 isolated TAPVC cases, 6 were missed prenatally and 1 case was prenatally diagnosed as intracardiac and postnatally proved to be mixed (intracardiac type + supracardiac type) by echocardiography. Of the 13 TAPVC live births, 4 infants died in the neonatal period without operation. Of the nine infants undergoing the operation, five recuperated and survived; one survived but had complications with superior vena cava obstruction and collateral circulation formation, and three died postoperatively.

Conclusion:

The four-step prenatal ultrasound procedure can comprehensively and systematically evaluate fetal TAPVC, detailing the classification, potential obstruction, and associated malformations. It provides substantial support for subsequent prenatal counseling and neonatal assessment. The retrospective analysis also reveals that isolated TAPVC is more prone to be missed in diagnosis.

Introduction

Total anomalous pulmonary venous connection (TAPVC) is a relatively rare cyanotic congenital heart disease, accounting for approximately 0.5%–2% of postnatal congenital heart diseases, in which all pulmonary veins (PVs) are not connected to the left atrium (LA) but directly or indirectly to the right atrium (RA) (1). According to different drainage pathways, TAPVC can be divided into four types: supracardiac, intracardiac, infracardiac, and mixed, with supracardiac type being the most common malformation and accounting for about 43% of all cases (2). TAPVC can occur alone or can accompany other deformities, and the most common comorbidity is right atrium isomerism (RAI) (3). Postnatally, TAPVC neonates often suffer from severe expiratory dyspnea, cyanosis, heart failure, etc. In case of pulmonary vein obstruction (PVO) complication, prompt emergency surgery is required; otherwise, most would die in the neonatal period. The prognosis of TAPVC is related to the specific subtypes, the presence of PVO, and associated malformations (4, 5). Therefore, an accurate prenatal diagnosis of TAPVC is of great significance for neonatal prognosis.

To date, the accuracy of TAPVC diagnosis varies significantly across different countries, regions, and institutions (3, 6). Some new ultrasound indicators or methods have been proposed to improve the prenatal diagnosis of TAPVC. For instances, post-LA space has been suggested as a potential indicator for prenatal diagnosis of TAPVC in many studies (7, 8). A four-dimensional spatiotemporal image correlation has been used to diagnose fetal TAPVC (9). Additionally, fetal PV variability index and vertical vein (VV) flow velocity have shown to predict postpartum PVO (10). Artificial intelligence can also be used to assist in diagnosing TAPVC (11). The routine prenatal screening has also identified pulmonary venous connections on a four-chamber view (12). Available literature demonstrates that prenatal screening, color Doppler, and spectral Doppler can identify 80% of suspected TAPVC, 34% of PVO, 59% of ventricular imbalance, 58% of increased LA posterior space, and 59% of VV cases (3). However, much remains to be desired with regard to a systemic assessment of TAPVC.

Given that the detection of PVO and the identification of its drainage pathway, an indispensable procedure of ultrasound diagnosis, are related to the prognosis of neonates with TAPVC, we proposed a four-step ultrasound approach to diagnose fetal TAPVC systematically, which demonstrated a favorable accuracy in prenatal diagnosis of TAPVC. The proposed method can provide a reliable support for prenatal consultation and clinical decision-making.

Materials and methods

A total of 62 TAPVC fetuses underwent prenatal ultrasound examination in the Fujian Maternal and Child Health Hospital between June 2012 and June 2022, and were confirmed by postnatal echocardiography, surgical procedures, or postabortion autopsy. The clinical data and imaging findings of these TAPVC cases were retrospectively analyzed. Inclusive criteria were as follows: the fetuses with TAPVC were examined by systematic ultrasonography and verified by the above-mentioned means in our hospital. The exclusion criteria were as follows: the fetuses with TAPVC that were not verified postnatally or pathologically; RAI cases that indicated the entry of PV into the atrium; or cases that reported incomplete clinical data or no follow-up. The study protocol was reviewed and approved by the Ethics Committee of the Fujian Maternal and Child Health Hospital. Informed consent was obtained from all pregnant women.

Prenatal ultrasonography

For prenatal ultrasonography, GE Voluson E8 and E10 high-resolution color Doppler ultrasound diagnostic instruments were employed, with the frequency of the convex array probe set at 2–9 MHZ, and the conditions of middle and late pregnancy and fetal heart examination were selected. The fetuses were systematically evaluated following the ISUOG guidelines for the prenatal ultrasonography (13, 14). TAPVC was suspected with the presence of any of the following signs: a small LA, an increased distance from the LA to the descending aorta, a smooth posterior wall of the LA, unobservable orifices of the PV, evident extra vessels and centrifugal venous flow in some sections of the heart, and an abnormal dilated vein [e.g., superior vena cava (SVC), innominate vein (INN), azygos vein (AZV), inferior vena cava (IVC), or coronary sinus (CS)]. The suspected TAPVC cases were further assessed by a four-step ultrasound procedure: (1) no connection was observed between all the PVs and the LA, in which the orifices of the PV were detected by two-dimensional echocardiography and color Doppler flow imaging, and the waveform of the PV was examined by spectral Doppler imaging; (2) the presence of the common pulmonary vein (CPV) was detected behind and beside the LA, and the drainage route of PV to the systematic vein via the CPV and VV was traced, on which the classification of TAPVC was based; (3) the presence and location of obstruction of the pulmonary venous drainage pathway were assessed by color Doppler and spectral Doppler imaging, in which color Doppler flow imaging may indicate turbulent blood flow at the site of obstruction, with a maximum flow velocity above 50 cm/s (15); (4) the fetal cardiac structures and extracardiac systems were examined in detail to determine the presence of intracardiac and extracardiac malformations.

Postnatal verification

All the prenatally diagnosed fetal TAPVC cases underwent a multidisciplinary consultation. For cases of termination of pregnancy (TOP), autopsy was performed, with informed consent obtained from the parents, by either local anatomy or combined casting of the thoracic and abdominal organs, in which all specimens were archived, photographed, videotaped, and recorded. For live births, echocardiography or other imaging examinations were performed postnatally, in which Phillips EPIQ 7C was employed for neonatal echocardiography, with the frequency of phased array probes set at 3–8 MHz. These live births all received follow-ups.

Statistical analysis

The data were analyzed with SPSS 25.0. The quantitative data displayed a normal distribution with homogeneous variance and were expressed as mean ± SD. For qualitative data, frequency (N) and percentage (%) were used. Comparisons were analyzed by the chi-square test with continuity correction. A value of P <0.05 was considered statistically significant.

Results

Data overview

From June 2012 to June 2022, 158,763 pregnant women received prenatal ultrasonography and 84 cases of TAPVC were identified (5‰). Among them, the following cases were excluded from the study: 11 cases of loss to follow-up, 1 case of CPV atresia by postnatal autopsy, and 10 cases of RAI with PV entry into the atrium; 50 cases received TOP, of which 49 were confirmed as TAPVC by local pathological anatomy or combined casting of organs in thoracic and abdominal cavity; 6 cases chose to continue pregnancy and 7 were missed to be diagnosed prenatally. Live TAPVC infants suffered from cyanotic and respiratory distress, and the diagnosis was confirmed by echocardiography. Finally, 62 cases were included in the study (Figure 1). The mean age of the 62 pregnant women was 27.7 ± 3.5 years (19–36 years), and the mean gestational age (GA) was 25.56 ± 3.95 weeks (20.3–38 weeks). Of the 62 fetuses, 59 were singleton pregnancies and 3 were twin pregnancies (one of the fetuses was TAPVC). Among the 13 live TAPVC births, 4 infants died in the neonatal period without operation and 9 infants underwent surgery, including 5 total recoveries, 1 survival but with complication of SVC obstruction and collateral circulation, and 3 deaths after surgery.

Figure 1

Figure 1

Flowchart of the enrollment in the study.

Classification and sonographic characterization of TAPVC

Of the 62 TAPVC cases, there were 20 supracardiac cases (32%), 12 intracardiac cases (19%), 21 infracardiac cases (34%), and 9 cases of mixed type (15%). Of the 20 cases of supracardiac TAPVC, CPV and single VV were found in 16 cases, of which 9 cases finally regurgitated into SVC, 4 into INN, 2 into AZV, 1 into left internal jugular vein (LIJV), and double VVs were reported in the remaining four cases, which regurgitated into SVC and INN (Table 1). Of the 12 cases with intracardiac TAPVC, 9 cases regurgitated into the RA through the CS and 3 cases drained directly into the RA (Table 2). Of the 21 cases of infracardiac TAPVC, 16 cases drained into the portal vein, 3 cases into ductus venous (DV), 1 into the hepatic vein (HV), and 1 into IVC (Table 3). Of the 9 cases of mixed TAPVC, 8 cases were combined with supracardiac and infracardiac drainage and 1 case was combined with supracardiac and intracardiac drainage (Table 4).

Table 1

GAVentricle imbalancePost-LA space enlargeAbsent PV-LA connectionCPV3VV additional vesselProminent SVCSite of connectionPVOAssociated malformationOutcomePostnatal diagnosis
125YYYYYYCPV-VV-INN-SVCYIsolatedTOPConfirmed
225.5NYYYNYCPV-SVCNIsolatedTOPConfirmed
334.5YYYYYYCPV-VV-SVC; LSPV-INNYIsolatedTOPConfirmed
424.6NYYYYYCPV-RVV-SVC; LIPV-LVV-INNYIsolatedTOPConfirmed
535.4YYYYYYCPV-AZV-SVCYIsolatedTOPConfirmed
628NYYYYYCPV-VV-INN-SVCNIsolatedTOPConfirmed
724NYNYNNCPV-VV-INN-SVCYIsolatedLive birthMissed
827YYYYYYCPV-VV-LSVCNRAI, AVSD, DORV, PS, BSVCLive birthConfirmed
924.3YYYYYYCPV-VV-LSVCYRAI, AVSD, DORV, PS, BSVCTOPConfirmed
1022.5YYYYYYCPV-VV-INN-SVCNRAI, DX, AVSD, PA, RAA, ASVRTOPConfirmed
1123.5NYYYYYCPV-AZV-SVCNRAI, DX, AVSD, PA, RAA, AVSRTOPConfirmed
1224YYYYYYCPV-VV-SVCNRAI, AVSD, DORV, PSTOPConfirmed
1323.6YYYYYYLPV-CPV-VV-INN-SVC; RPV-SVCNRAI, AVSD, DORV, PA, RAATOPConfirmed
1423.5NYYYYYCPV-VV-SVCNRAI, SA, DOSV, PS, RAATOPConfirmed
1523.3NYYYYYCPV-VV-LIJVNRAI, SA, AVSD, DORV, PS, DLBCVLive birthConfirmed
1623.4NYYYYYLCPV-VV-LSVC; RCPV-VV-RSVCNRAI, DOSV, PS, BSVC, PRUVTOPConfirmed
1723.5YYYYYYCPV-VV-SVCNRAI, MS, PTA, BSVCTOPConfirmed
1824.2YYYYYYCPV-VV-SVCYRAI, DX, DORV, VSD, PATOPConfirmed
1924.3NYYYYYCPV-VV-SVCNRAI, LEVO, SA, SV, TGA, PSTOPConfirmed
2023.6NYYYNYCPV-SVCNDX, DOSV, AVSD, PSTOPConfirmed

Prenatal sonographic findings of supracardiac TAPVC.

TAPVC, total anomalous pulmonary venous connection; GA, gestational age; LA, left atrium; PV, pulmonary vein; CPV, common pulmonary vein; SVC, superior vena cava; PVO, pulmonary vein obstruction; VV, vertical vein; INN, innominate vein; TOP, termination of pregnancy; LSPV, left superior pulmonary vein; LIPV, left inferior pulmonary vein; AZV, azygos vein; LIJV, left internal jugular vein; RAI, right atrium isomerism; AVSD, atrioventricular septal defect; DORV, double outlet right ventricle; PS, pulmonary artery stenosis; PRUV, permanent right umbilical vein; VSD, interventricular septum; SV, single ventricle; TGA, transposition of great arteries; LSVC, left superior vena cave; PA, pulmonary atresia; 3VV, three vessel view; RVV, right vertical vein; LVV, left vertical vein; RPV, right pulmonary vein; LPV, left pulmonary vein; LCPV, left common pulmonary vein; RCPV, right pulmonary vein; RSVC, right superior vena cave; BSVC, bilateral superior vena cave; DX, dextrocardiac; RAA, right aortic arch; AVSR, abnormal systemic venous return; DOSV, double outlet single ventricle; DLBCV, dysplastic of left brachiocephalic vein; MS, mitral stenosis; LEVO, levocardia; SA, single atrium; PTA, persistent truncus arteriosus.

Table 2

GAVentricle imbalancePost-LA space enlargeAbsent of PV-LA connectionCPVDilated CSSite of connectionPVOAssociated malformationOutcomePostnatal diagnosis
124NYYNYPV-CSNIsolatedTOPConfirmed
228YYYYYCPV-CSNIsolatedLive birthConfirmed
325.2NYYYNCPV-RANIsolatedTOPConfirmed
423.2YYYYYCPV-CSNIsolatedTOPConfirmed
524.6NNYYNCPV-CSNIsolatedLive birthMissed
624.5NNYYNCPV-CSNIsolatedLive birthMissed
729.5NNYYNCPV-CSNIsolatedLive birthMissed
826.6YYYNYPV-CSNLSVCTOPConfirmed
928.1YYYYYCPV-CSNVSD, CoATOPConfirmed
1023.4YYYYYCPV-RANLSVCTOPConfirmed
1120.3NYYYYCPV-CSYDOSV, MA, PS, RAATOPConfirmed
1225.6NNYNNPV-RANDORV, VSD, PA, RAA, BSVCTOPConfirmed

Prenatal sonographic findings of intracardiac TAPVC.

TAPVC, total anomalous pulmonary venous connection; GA, gestational age; LA, left atrium; CPV, common pulmonary vein; CS, coronary sinus; PVO, pulmonary vein obstruction; PV, pulmonary vein; TOP, termination of pregnancy; RA, right atrium; VSD, interventricular septum; PS, pulmonary artery stenosis; DORV, double outlet right ventricle; LSVC, left superior vena cave; PA, pulmonary atresia; CoA, aortic coarctation; DOSV, double outlet single ventricle; MA, mitral atresia; RAA, right aortic arch; DORV, double outlet right ventricle; BSVC, bilateral superior vena cave.

Table 3

GAVentricle imbalancePost-LA space enlargeAbsent of PV-LA connectionCPVAbdominal additional vesselSite of connectionPVOAssociated malformationOutcomePostnatal diagnosis
122.2YNYYYCPV-VV-DVYIsolatedTOPConfirmed
224.1NYYYYCPV-VV-portal veinNIsolatedTOPConfirmed
323.3YYYYYCPV-VV-DVYIsolatedLive birthConfirmed
423NNNYNCPV-VV-HVYIsolatedLive birthMissed
532.2YYYYYCPV-VV-portal veinYVSD, PA, oligoamniosTOPConfirmed
623.3YYYYYCPV-VV-portal veinYAVSD, PTA, BSVCTOPConfirmed
722NYNYYCPV-VV-portal veinNTOF, holoprosencephalyTOPConfirmed
823.4NYYYYCPV-VV-DVNRAI, SV, ASD, PATOPConfirmed
924.4NYYYYCPV-VV- portal veinNRAI, DX, AVSD, SV, TGATOPConfirmed
1025YYYYYCPV-VV-PVNRAI, MA, VSD, DORV, PS, BSVCTOPConfirmed
1123.4YYYYYCPV-VV-portal veinNRAI, DX, AVSD, DORV, PA, BSVCTOPConfirmed
1222.3YYYYYCPV-VV- portal veinNRAI, AVSD, DORV, PS, RAATOPConfirmed
1328.5NYYYYCPV-VV-portal veinNRAI, AVSD, DOSV, PS, hiatal herniaTOPConfirmed
1424.4YYYYYCPV-VV-portal veinNRAI, AVSD, DORV, PSTOPConfirmed
1522.4NYYYYCPV-VV-portal veinNRAI, SA, SV, PATOPConfirmed
1623.3YYYYYCPV-VV-portal veinNRAI, DOSV, ASVRTOPConfirmed
1723.4YYYYYCPV-VV-portal veinNRAI, AVSD, DORV, PS, ASVRTOPConfirmed
1822.2NYYYYCPV-VV-portal veinNRAI, AVSD, DOSV, PS, BSVCTOPConfirmed
1923.4YYYYYCPV-VV-portal veinNRAI, AVSD, DOSV, PS, BSVC, ASVRTOPConfirmed
2024.1YYYYYCPV-VV-portal veinNRAI, AVSD, DORV, PS, ASVRTOPConfirmed
2138.2NYNYYCPV-VV-IVCNRAI, SA, SV, CoATOPConfirmed

Prenatal sonographic findings of infracardiac TAPVC.

TAPVC, total anomalous pulmonary venous connection; GA, gestational age; LA, left atrium; CPV, common pulmonary vein; PV, pulmonary vein; PVO, pulmonary vein obstruction; VV, vertical vein; DV, ductus venous; TOP, termination of pregnancy; HV, hepatic vein; VSD, interventricular septum; IVC, inferior vena cava; AVSD, atrioventricular septal defect; RAI, right atrium isomerism; SV, single ventricle; TGA, transposition of great arteries; DORV, double outlet right ventricle; TOF, tetralogy of fallot; SA, single atrium; PA, pulmonary atresia; PTA, persistent truncus arteriosus; BSVC, bilateral superior vena cave; ASD, atrium septal defect; DX, dextrocardiac; MA, mitral atresia; DORV, double outlet right ventricle; RAA, right aortic arch; AVSR, abnormal systemic venous return; DOSV, double outlet single ventricle; CoA, aortic coarctation.

Table 4

GAVentricle imbalancePost-LA space enlargeAbsent of PV-LA connectionCPVAdditional vesselSite of connectionPVOAssociated malformationOutcomePostnatal diagnosis
122.2YYYNNPV-CS; LSPV-VV-INN-SVCYIsolatedLive birthModified
223.1YYYYYCPV-VV-INN-SVC; LIPV-IVCYIsolatedTOPConfirmed
322.5NNNYNCPV-VV- portal vein; LSPV-SVCNIsolatedLive birthMissed
432.5YYYYYCPV-VV-INN-SVC; CPV-VV-portal veinNTR (severe)TOPConfirmed
522.5NNNNNRPV-VV-SVC; LPV-VV-portal veinNRAA, SUALive birthMissed
627.6NYYYYCPV-VV-portal vein; RSPV-SVCNRAI, DORV, VSDLive birthConfirmed
723.5NYYYYCPV-VV-INN-SVC; LIPV-VV-portal veinYRAI, SA. DOSV, AVSD, PA, ASVRTOPConfirmed
831.1YYYYYSCPV-VV-SVC; ICPV-VV-portal veinNRAI, AVSD, DORV, PSTOPConfirmed
922.6YYYYYSCPV-SVC; ICPV-VV-DVYRAI, AVSD, DORV, PA, RAATOPConfirmed

Prenatal sonographic findings of mixed TAPVC.

TAPVC, total anomalous pulmonary venous connection; GA, gestational age; LA, left atrium; CPV, common pulmonary vein; PV, pulmonary vein; PVO, pulmonary vein obstruction; CS, coronary sinus; LSPV, left superior pulmonary vein; VV, vertical vein; INN, innominate vein; SVC, superior vena cava; TOP, termination of pregnancy; LIPV, left inferior pulmonary vein; IVC, inferior vena cava; RSPV, right superior pulmonary vein; LIPV, left inferior pulmonary vein; SUA, single umbilical artery; VSD, interventricular septum; AVSD, atrioventricular septal defect; PS, pulmonary artery stenosis; RAI, right atrium isomerism; SCPV, superior common pulmonary vein; ICPV, inferior common pulmonary vein; RPV, right pulmonary vein; LPV, left pulmonary vein; TR, tricuspid regurgitation; RAA, right aortic arch; DORV, double outlet right ventricle; DOSV, double outlet single ventricle; SA, single atrium; PA, pulmonary atresia; ASVR, abnormal systemic venous return.

The common sonographic characteristics of TAPVC included small LA, smooth posterior wall of the LA, no PV orifice, increased distance between the LA and the descending aorta, and a continuous flow spectrum of the PV. CPV was shown in 56 cases, which appeared as an additional vessel behind or beside the LA. The sonographic image varied for different types of TAPVC. The supracardiac TAPVC featured an ascending VV, which was an additional vessel on a three-vessel trachea view and appeared as a centrifugal venous flow with dilated drainage site via color Doppler flow imaging (Figure 2). Echocardiographic findings of intracardiac TAPVC showed that the CPV either flew back into the RA through dilated CS or drained directly into the RA (Figure 3). The sonographic appearance of infracardiac TAPVC revealed a descending VV, an additional vessel in the transverse section of the abdomen, which appeared as a downward centrifugal vessel into the liver along with the IVC and the descending aorta in the sagittal section of the abdomen (Figure 4). Mixed TAPVC displayed multiple anomalous pulmonary venous drainage pathways, featuring two or more of the above ultrasonic findings (Figure 5).

Figure 2

Figure 2

The prenatal sonographic features of supracardiac TAPVC. (A) The posterior wall of LA was smooth without orifice of PV, the pulmonary venous confluence behind the LA. (B) The left and right PVs converging to form a common PV truck, the CPV going upward as VV. (C) The VV drained into the SVC via the LBCV. (D) The entire drainage route of PVs. TAPVC, total anomalous pulmonary venous connection; PV, pulmonary vein; LA, left atrium; CPV, common pulmonary vein; VV, vertical vein; SVC, superior vena cava; LBCV, left brachiocephalic vein.

Figure 3

Figure 3

The prenatal and postnatal sonographic features of intracardiac TAPVC. (A) The four-chamber view showed ventricular discrepancy and no connection between PVs and LA. (B) The PVs drained into RA via dilated CS. (C) The entire drainage route of anomalous PVs. (D) The obvious asymmetry on the four-chamber view after birth. (E) All the PVs were not connected with LA. (F) The CPV drained into RA via dilated CS. TAPVC, total anomalous pulmonary venous connection; PV, pulmonary vein; LA, left atrium; RA, right atrium; CPV, common pulmonary vein; CS, coronary sinus.

Figure 4

Figure 4

The sonographic features of infracardiac TAPVC and postnatal confirmation. (A) CPV was located behind the LA, with an increased posterior left atrium space. (B) The Doppler spectrum of PV was continuous instead of pulsatile. (C) The VV appeared as an extra vessel in the transabdominal section. (D) The VV drained into DV in a turbulent flow. (E) The obstruction was confirmed postnatally. (F) The CTA showed the entire drainage route of PVs. TAPVC, total anomalous pulmonary venous connection; PV, pulmonary vein; LA, left atrium; CPV, common pulmonary vein; VV, vertical vein; DV, ductus venous; CTA, computerized tomographic angiography.

Figure 5

Figure 5

The sonographic features of mixed TAPVC and postnatal anatomic cardiovascular casting findings. (A) A dilated IVC in transabdominal section. (B) The ventricles were asymmetrical and the CPV was located behind the LA. (C) The VV appeared as an extra vessel behind the aorta. (D) The color Doppler showed the drainage of the RSPV, RLPV, and the LSPV into the LBCV via VV. (E) The LLPV drained into IVC. (F,G) Obstruction was confirmed in both the supracardiac and infracardiac pathways. (H) The entire drainage route of all PVs. (I): The postnatal casting of the TAPVC heart showed the RSPV, RLPV, and LSPV drainage into LBCV via the VV, and the LLPV drainage into the IVC. TAPVC, total anomalous pulmonary venous connection; IVC, inferior vena cava; CPV, common pulmonary vein; LA, left atrium; VV, vertical vein; RSPV, right superior pulmonary vein; RLPV, right low pulmonary vein; LSPV, left superior pulmonary vein; LBCV, left brachiocephalic vein; LLPV, left low pulmonary vein.

The obstruction of pulmonary veins in fetal TAPVC

Of the 62 cases of TAPVC, 17 cases were complicated with PVO, including 7 cases of supracardiac type (42%), 5 cases of infracardiac type (29%), 4 cases of mixed type (24%), and 1 case of intracardiac type (6%), with no statistical PVO difference among the different groups of TAPVC (P > 0.05) (Table 5). Among the seven supracardiac TAPVC cases, five cases reported PVO at the opening of the ascending VV into the SVC, one case at the opening of the ascending VV into the AZV, and one case at the VV crossing the bifurcation of the pulmonary artery. Of the five infracardiac TAPVC cases, the obstruction was located at the confluence of the descending VV into the DV in three cases and at the confluence of the descending VV into the PV in two cases. In the intracardiac TAPVC case, four PVs formed a CPV and the VV were tortuous, in which the obstruction was located at the bifurcation of pulmonary artery and confluent to the CS. Of the four cases of mixed TAPVC, three cases reported a mixture of supracardiac and infracardiac TAPVC, in which the obstruction occurred during the infracardiac drainage when the descending VV entered the IVC, portal vein, and DV, and one case displaying obstruction in the supracardiac route, with the ascending VV crossing the left pulmonary artery. The remaining case displayed a mixture of intracardiac and supracardiac TAPVC, in which the obstruction was found in the supracardiac and intracardiac pathways, respectively, at the point where the left inferior pulmonary vein (LIPV) joined the CPV and at the point where the VV joined the INN. All the PVO cases displayed the sonographic features of the tortuous and slender obstructive site, with turbulent blood flow by color Doppler imaging and continuous high-speed blood flow by spectrum Doppler imaging at a maximum velocity of 110 ± 33 cm/s (58–170 cm/s).

Table 5

ClassificationDrainage route (n)PVO*
SupracardiacCPV-VV-RSVC (7)1
Bilateral VV (4)2
CPV-VV-LBCV-RSVC (4)2
CPV-VV-LSVC (2)1
CPV-AZV-SVC (2)1
CPV-VV-LIJV (1)0
Total20/627/20
IntracardiacCPV-CS (7)1
PV-CS (2)0
CPV-RA (2)0
PV-RA (1)0
Total12/621/12
InfracardiacCPV-VV-portal vein (16)2
CPV-VV-DV (3)2
CPV-VV-IVC (1)1
CPV-VV-HV (1)0
Total21/625/21
Mixed type (9/62)CPV-SVC and PV-VV-portal vein (6)1
SCPV-VV-SVC and ICPV-VV-DV (1)1
CPV-VV-SVC and LIPV- IVC (1)1
LSPV-VV-INN-SVC and PV-CS (1)1
Total9/624/9

The drainage route and obstruction of TAPVC.

TAPVC, total anomalous pulmonary venous connection; PVO, pulmonary vein obstruction; CPV, common pulmonary vein; PV, pulmonary vein; VV, vertical vein; LBCV, left brachiocephalic vein; SVC, superior vena cava; LIJV, left internal jugular vein; CS, coronary sinus; RA, right atrium; DV, ductus venous; IVC, inferior vena cava; HV, hepatic vein; SCPV, superior common pulmonary vein; ICPV, inferior common pulmonary vein; INN, innominate vein; RSVC, right superior vena cave; LSVC, left superior vena cave.

*

P-value was obtained from chi-square test with continuity correction. The difference between PVO in four groups is not statistical significance (P = 0.142).

The associated malformations of the fetal TAPVC

Of the 62 TAPVC cases, 41 cases were complicated with other intracardiac and extracardiac malformations, including 30 RAI cases and 11 cases with other intracardiac and extracardiac malformations, and the remaining 21 cases were isolated TAPVC. In the 30 TAPVC cases combined with RAI, the common concomitant malformations included atrioventricular septal defect (AVSD) (19/30), pulmonary artery stenosis (PS) (16/30), double outlet right ventricle (DORV) (15/30), single ventricle (SV) (12/30), etc., and the rare complicated malformations were interventricular septum (VSD) (2/30), transposition of great arteries (TGA) (2/30), etc. (Figure 6A). In the 11 TAPVC cases complicated with other cardiac malformations, common concomitant malformations were VSD (3/11), right aortic arch (3/11), left superior vena cave (LSVC) (2/11), PS (2/11), etc. (Figure 6B). TAPVC cases combined with extracardiac malformations displayed cleft lip and palate, holoprosencephaly, hiatal hernia, oligohydramnios, and permanent right umbilical vein (PRUV), one case per category, and single umbilical artery (SUA) in two cases. Of the 62 TAPVC cases, seven cases underwent chromosome tests, which reported chromosome normality in six cases and inversion of chromosome 9 in one case.

Figure 6

Figure 6

Obvious differences of the associated intracardiac malformations between TAPVC with RAI (A) and without RAI (B). TAPVC with RAI is usually associated with a series of complex intracardiac anomalies and TAPVC without RAI can be isolated or accompanied with other anomalies. TAPVC, total anomalous pulmonary venous connection; right atrium isomerism.

The diagnostic accuracy of the four-step prenatal ultrasonography

Of the 62 cases of TAPVC, the diagnostic accuracy of the four different TAPVC types by the four-step prenatal ultrasonography was 95%, 75%, 95%, and 77%, respectively, with no statistical significance (P > 0.05) (Table 6). Thirty cases complicated with RAI and 10 cases combined with other intracardiac and extracardiac abnormalities were correctly diagnosed by the proposed prenatal ultrasonic procedure, while 1 case was missed, which was a mixed type (supracardiac and infracardiac) with right aortic arch and SUA. Of the 21 isolated cases of TAPVC, 14 cases were correctly diagnosed; 1 case was diagnosed as intracardiac type prenatally, which was postnatally confirmed to be a mixed type (supracardiac and intracardiac) with obstruction of the supracardiac and intracardiac drainage pathway by echocardiography; 6 cases were missed. As shown in Table 6, the proposed four-step prenatal ultrasonography reported a higher accuracy in diagnosing TAPVC cases that were complicated with RAI (P < 0.05).

Table 6

ClassificationCorrect (n)Incorrect (n)P*
Supracardiac1910.195
Intracardiac93
Infracardiac201
Mixed72
Complicated with RAI3000.003
Other anomalies101
Isolated156

Comparison of the diagnostic rate of different types of TAPVC and comparison of the diagnostic rate of TAPVC complicated with other malformations.

TAPVC, total anomalous pulmonary venous connection; RAI, right atrium isomerism.

The difference of diagnostic rate between four TAPVC groups is not statistically significant (P = 0.195). The difference of diagnostic rate between TAPVC complicated with other malformations is statistically significant (P = 0.003).

*

P-value was obtained from chi-square test with continuity correction.

Discussion

Prenatal diagnosis of TAPVC has always been a great challenge, especially in isolated cases (16). Due to its low incidence and difficulty in obtaining detailed images, it is rarely detected during obstetric screening in the second trimester of pregnancy (17). Diagnostic accuracy has been improved thanks to sonographic advances and experience accumulation in the past decade. Several retrospective studies have documented many suspicious signs of TAPVC during prenatal ultrasound screening, including a small LA, lengthened distance between the LA and the descending aorta, the smooth posterior wall of the LA, obscured orifices of the PV, additional vessels in some sections, centrifugal venous flow, and dilatated fetal systemic veins (e.g., SVC, INN, AZV, IVC, or CS) (15). When the above-mentioned suspicious TAPVC diagnostic clues appear, the use of prenatal ultrasound four-step observation can help improve the diagnosis and classification of TAPVC, especially when TAPVC is associated with other malformations. In this article, we found that after postpartum validation or pathological comparison, the prenatal correct diagnosis rates of the supracardiac, intracardiac, infracardiac, and mixed types were 95%, 75%, 95%, and 77%, respectively. Thirty TAPVC cases with RAI were accurately detected by the proposed prenatal ultrasonography, though one case of TAPVC with other extracardiac and intracardiac malformations was missed. Six cases of isolated TAPVC were missed. The potential explanation for missed diagnosis may lie in the following considerations: (1) The entry of fetal PV into the LA is falsely identified during the examination, since the echoes of bronchial and pulmonary arteries may interfere with the orifices of the PVs at the top of the LA and may be mistaken for the connection with the LA; (2) Due to the small size of the fetal PV, the fetal position, and the thickness of abdominal wall of the pregnant woman, two-dimensional ultrasonography may not clearly delineate the lumen of the PV; (3) The dilated systemic veins and VV in the drainage site were overlooked because of inexperience. These weaknesses may be remedied by adjusting the blood flow velocity scale to about 20 cm/s during color Doppler flow imaging and verifying the connection by spectrum Doppler imaging. In addition, an extra vessel in the trachea section or abdominal cross-section is an important indicator for TAPVC diagnosis.

Of the four types of TAPVC, the infracardiac and mixed types of TAPVC have a poor prognosis (18). Even for the same type, the prognosis differs for different drainage paths. For example, for different subtypes of supracardiac TAPVC, direct access to the right SVC via the right VV is more likely to result in postoperative PVO (19). The prognosis of intracardiac TAPVC is generally considered good (20). In this study, four cases of isolated intracardiac TAPVC had a good prognosis after surgical treatment. However, the prognosis of intracardiac TAPVC varies for different sites of connection. Studies have shown that the number of PV orifices, the length of the drainage path, and the drainage through the roof of the RA are associated with postoperative PVO (21). Therefore, the prenatal diagnosis of TAPVC should delineate not only the type of TAPVC but also the specific connection of ectopic PV and the length of the drainage path.

PVO is also an essential factor for a poor prognosis, and preoperative PVO is closely associated with mortality (18, 22). The available literature indicates that preoperative PVO occurs in approximately 25%–50% of cases (23, 24) and the incidence of PVO in prenatal TAPVC fetuses is as high as 34.1% (95% CI: 22.7%–47.7%) (3), signifying that one-third of the cases are likely to show evidence of prenatal obstruction. Our cohort found PVO in 17 cases (17/62, 27.4%): prenatally in 14 cases and postnatally in 3 cases. The disparity may be attributed to the following facts: as, in the current study, the average GA for the prenatal diagnosis was 25.56 ± 3.95 weeks (20.3–38 weeks) and most cases were diagnosed in the second trimester, the minor pulmonary blood flow may result in unnoticeable or no obstruction while with the progression of gestation, the increase in pulmonary blood flow may induce the obstruction; most cases in the current study received induced labor after TAPVC diagnosis and no follow-up was conducted in late pregnancy. Therefore, fewer PVO cases were diagnosed in this cohort.

PV stenosis is often caused by insertion site stenosis and external organ compression, and the longer the drainage path is, the more likely it is to be obstructed. PVO can occur at any site and aggravate during pregnancy, especially when pulmonary vascular resistance decreases, leading to increased blood flow (25). PVO can also lead to PV remodeling and even progress to atresia (26). Studies have suggested that an earlier occurrence of PVO may indicate a poorer prognosis, as it will lead to pulmonary vascular remodeling and may even compromise the efficacy of a successful surgery (26). In this study, of the 13 live births, 4 PVO infants died in the neonatal period and the prognosis of fetuses without PVO was good. Therefore, PVO should rank as an essential part of prenatal TAPVC evaluation.

TAPVC can be combined with a series of intracardiac and extracardiac malformations. The complication with RAI, one of the most common malformations in TAPVC, is associated with a worse prognosis due to faster disease progression and a greater chance of multi-operation after repair of the PV (27). In our cohort, 30 cases (30/62, 48%) were complicated with RAI. RAI is characterized by complex intracardiac abnormalities, such as incongruent visceral atria position, complete AVSD, DORV, and right ventricular outflow tract obstruction (28). Due to the bilateral right atrial structure, evaluation of pulmonary venous return is an important step in diagnosing RAI (29, 30). In addition to RAI, TAPVC may be associated with other extracardiac and intracardiac malformations, such as TGA, tetralogy of fallot (TOF), single atrium (SA), persistent truncus arteriosus (PTA), tricuspid atresia (TA), hypoplastic left heart syndrome, pulmonary atresia (PA), VSD, aortic coarctation (CoA), and other abnormalities (25). In this cohort, 11 cases were complicated with other intracardiac or extracardiac malformations. The associated anomalies, especially complex intracardiac anomalies that require secondary surgery, are also associated with a poor prognosis of TAPVC. Some deformations require no remedy or can be simultaneously corrected during the repair of the PV, in which the deformation may not be a risk factor for postoperative death (5).

The mode of inheritance of TAPVC remains unknown. However, it may be a single gene inheritance according to the existent literature (25). In the affected families, the abnormal pulmonary venous connection is a common characteristic, but the location of the abnormal connection is inconsistent (31). TAPVC is associated with several syndromes, such as asplenia, polysplenia, and Cat's eye syndrome (25). In the current study, the chromosome examination of seven cases revealed chromosome 9 inversion in one case and no abnormality in the other six cases.

Limitation

Several limitations should be noted in the current study. First, as a retrospective study, the archived images may affect the quality and integrity of data sources. Second, the sample size is quite small. In this study, only 13 TAPVC fetuses were retrieved for analysis, which was unfavorable for evaluating the prognosis of TAPVC. Third, the accuracy of the proposed four-step prenatal ultrasonography may be compromised by the complexity of the enrolled cases, in which the RAI complication and isolated TAPVC may confound the results of the analysis. Finally, a more detailed spectrum analysis of the VV and anomalous PV should be provided.

Conclusions

The proposed four-step ultrasonography can satisfactorily delineate fetal TAPVC classification, the presence of PVO, and intracardiac and extracardiac abnormalities, which offers beneficial support for prenatal counseling and prognostic improvement of postnatal TAPVC. The retrospective analysis also reveals that isolated TAPVC is more prone to be missed in diagnosis.

Statements

Data availability statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding authors.

Ethics statement

The studies involving human participants were reviewed and approved by Ethics Committee of Fujian Maternal and Child Health Center. Written informed consent to participate in this study was provided by the participants’ legal guardian/next of kin. Written informed consent was obtained from the individual(s), and minor(s)' legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.

Author contributions

XQ and ZW designed and supervised the study. XX, QW, and MX worked on the literature review. ZW, QW, SG, XX, and WL focused on imaging acquisition, data collection, and analysis. XX performed the statistical analysis. QW, XX, and MX drafted the manuscript. HM, ML, and BH worked on the editing. All authors contributed to the article and approved the submitted version.

Funding

This publication was supported by Joint Funds for the Innovation of Science and Technology, Fujian province (2020Y9156); this publication was also supported by Fujian Natural Science Foundation (2021J01420).

Acknowledgments

The authors thank for the support from Department of Pathology, Department of radiology, and Department of Obstetrics, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China. We also thank all the patients and families for their understanding and support.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.

    HoffmanJI. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol. (1995) 16(4):155–65. 10.1007/BF00794186

  • 2.

    TongsongTLuewanSJatavanPTongprasertFSukpanK. A simple rule for prenatal diagnosis of total anomalous pulmonary venous return. J Ultrasound Med. (2016) 35(7):1601–7. 10.7863/ultra.15.08016

  • 3.

    PaladiniDPistorioAWuLHMeccarielloGLeiTTuoGet alPrenatal diagnosis of total and partial anomalous pulmonary venous connection: multicenter cohort study and meta-analysis. Ultrasound Obstet Gynecol. (2018) 52(1):24–34. 10.1002/uog.18907

  • 4.

    ValsangiacomoERHornbergerLKBarreaCSmallhornJFYooSJ. Partial and total anomalous pulmonary venous connection in the fetus: two-dimensional and Doppler echocardiographic findings. Ultrasound Obstet Gynecol. (2003) 22(3):257–63. 10.1002/uog.214

  • 5.

    SealeANUemuraHWebberSAPartridgeJRoughtonMHoSYet alTotal anomalous pulmonary venous connection: morphology and outcome from an international population-based study. Circulation. (2010) 122(25):2718–26. 10.1161/CIRCULATIONAHA.110.940825

  • 6.

    SealeANCarvalhoJSGardinerHMMellanderMRoughtonMSimpsonJet alTotal anomalous pulmonary venous connection: impact of prenatal diagnosis. Ultrasound Obstet Gynecol. (2012) 40(3):310–8. 10.1002/uog.11093

  • 7.

    MaoYKZhaoBWZhengFHWangBPengXHChenRet alZ-scores for fetal left atrial size and left atrium-descending aorta distance in fetuses with isolated total anomalous pulmonary venous connection. Prenat Diagn. (2017) 37(10):992–1000. 10.1002/pd.5119

  • 8.

    HanJLiTWuWZhangYLiuXGuXet alPost-left atrium space index in fetuses with total anomalous pulmonary venous connection and other congenital heart diseases. J Ultrasound Med. (2020) 39(12):2405–12. 10.1002/jum.15362

  • 9.

    PengRXieHNDuLShiHJZhengJZhuYX. Four-dimensional sonography with spatiotemporal image correlation and tomographic ultrasound imaging in the prenatal diagnosis of anomalous pulmonary venous connections. J Ultrasound Med. (2012) 31(10):1651–8. 10.7863/jum.2012.31.10.1651

  • 10.

    CampbellMJWhiteBRRychikJLinderJFaerberJATianZet alFetal Doppler echocardiographic assessment predicts severe postnatal obstruction in total anomalous pulmonary venous connection. J Am Soc Echocardiogr. (2022) 35(11):1168–75. 10.1016/j.echo.2022.07.007

  • 11.

    WangXYangTYZhangYYLiuXWZhangYSunLet alDiagnosis of fetal total anomalous pulmonary venous connection based on the post-left atrium space ratio using artificial intelligence. Prenat Diagn. (2022) 42(10):1323–31. 10.1002/pd.6220

  • 12.

    LaudyJAHuismanTWde RidderMAWladimiroffJW. Normal fetal pulmonary venous blood flow velocity. Ultrasound Obstet Gynecol. (1995) 6(4):277–81. 10.1046/j.1469-0705.1995.06040277.x

  • 13.

    CarvalhoJAllanLChaouiRCopelJDevoreGHecherKet alISUOG practice guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol. (2013) 41(3):348–59. 10.1002/uog.12403

  • 14.

    SalomonLJAlfirevicZBerghellaVBilardoCHernandez-AndradeEJohnsenSLet alPractice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. (2011) 37(1):116–26. 10.1002/uog.8831

  • 15.

    GanesanSBrookMMSilvermanNHMoon-GradyAJ. Prenatal findings in total anomalous pulmonary venous return: a diagnostic road map starts with obstetric screening views. J Ultrasound Med. (2014) 33(7):1193–207. 10.7863/ultra.33.7.1193

  • 16.

    LauxDFermontLBajolleFBoudjemlineYStirnemannJBonnetD. Prenatal diagnosis of isolated total anomalous pulmonary venous connection: a series of 10 cases. Ultrasound Obstet Gynecol. (2013) 41(3):291–7. 10.1002/uog.11186

  • 17.

    BromleyBEstroffJASandersSPParadRRobertsDFrigolettoFD Jret alFetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol. (1992) 166(5):1473–81. 10.1016/0002-9378(92)91622-H

  • 18.

    ShiGZhuZChenJOuYHongHNieZet alTotal anomalous pulmonary venous connection: the current management strategies in a pediatric cohort of 768 patients. Circulation. (2017) 135(1):48–58. 10.1161/CIRCULATIONAHA.116.023889

  • 19.

    LiuXLiufuRLiuTCenJYuJWenSet alSupracardiac total anomalous pulmonary venous connection type Ib: morphology and outcomes. J Thorac Cardiovasc Surg. (2022):S0022-5223(22)01066-2. 10.1016/j.jtcvs.2022.10.008

  • 20.

    ShiGZhuFWenCQiuLZhangHZhuZet alSingle-institution outcomes of surgical repair of infracardiac total anomalous pulmonary venous connection. J Thorac Cardiovasc Surg. (2021) 161(4):1408–17.e2. 10.1016/j.jtcvs.2020.06.023

  • 21.

    ShiGZhuFWenCYanYZhangHZhuZet alCardiac-type total anomalous pulmonary venous return is not benign. J Thorac Cardiovasc Sur. (2022) 165(2):449–59. 10.1016/j.jtcvs.2022.03.036

  • 22.

    HörerJNeurayCVogtMCleuziouJKasnar-SamprecJJelenaLet alWhat to expect after repair of total anomalous pulmonary venous connection: data from 193 patients and 2902 patient years. Eur J Cardiothorac Surg. (2013) 44:800–7. 10.1093/ejcts/ezt129

  • 23.

    KaramlouTGurofskyRAl SukhniEColesJGWilliamsWGCaldaroneCAet alFactors associated with mortality and reoperation in 377 children with total anomalous pulmonary venous connection. Circulation. (2007) 115(12):1591–8. 10.1161/CIRCULATIONAHA.106.635441

  • 24.

    HusainSAMaldonadoERaschDMichalekJTaylorRCurzonCet alTotal anomalous pulmonary venous connection: factors associated with mortality and recurrent pulmonary venous obstruction. Ann Thorac Surg. (2012) 94(3):825–31; discussion 31–2. 10.1016/j.athoracsur.2012.04.026

  • 25.

    MossAJAllenHD. Moss and Adams’ heart disease in infants, children, and adolescents: including the fetus and young adult. JAMA Pediatr. (2012) 150(7):774.

  • 26.

    SealeANWebberSAUemuraHPartridgeJRoughtonMHoSYet alPulmonary vein stenosis: the UK, Ireland and Sweden collaborative study. Heart. (2009) 95(23):1944–9. 10.1136/hrt.2008.161356

  • 27.

    DomadiaSKumarSRVotava-SmithJKPruetzJD. Neonatal outcomes in total anomalous pulmonary venous return: the role of prenatal diagnosis and pulmonary venous obstruction. Pediatr Cardiol. (2018) 39(7):1346–54. 10.1007/s00246-018-1901-0

  • 28.

    TaketazuMLougheedJYooSJLimJSHornbergerLK. Spectrum of cardiovascular disease, accuracy of diagnosis, and outcome in fetal heterotaxy syndrome. Am J Cardiol. (2006) 97(5):720–4. 10.1016/j.amjcard.2005.09.119

  • 29.

    Atik-UganSSaltikIL. Prenatally diagnosed infracardiac total anomalous pulmonary venous connection: from the two sides of the spectrum. J Obstet Gynaecol. (2018) 38(8):1171–3. 10.1080/01443615.2017.1414775

  • 30.

    AllanLDSharlandGK. The echocardiographic diagnosis of totally anomalous pulmonary venous connection in the fetus. Heart. (2001) 85(4):433–7. 10.1136/heart.85.4.433

  • 31.

    AcevedoJMLeeSGotteinerNLayASPatelA. Total anomalous pulmonary venous connection (TAPVC): a familial cluster of 3 siblings. Echocardiography. (2017) 34(10):1531–5. 10.1111/echo.13665

Summary

Keywords

total anomalous pulmonary venous connection, four-step approach, postnatal verification, ultrasound, prenatal diagnosis

Citation

Xue X, Wu Q, Xiong M, Ling W, Guo S, Ma H, Huang B, Liu M, Qiu X and Weng Z (2023) Prenatal diagnosis and postnatal verification in fetuses with total anomalous pulmonary venous connection. Front. Pediatr. 11:1206032. doi: 10.3389/fped.2023.1206032

Received

14 April 2023

Accepted

22 May 2023

Published

07 June 2023

Volume

11 - 2023

Edited by

Liqun Sun, University of Toronto, Canada

Reviewed by

Qiao Zheng, The First Affiliated Hospital of Sun Yat-sen University, China Sun Chen, Shanghai Jiao Tong University, China

Updates

Copyright

*Correspondence: Zongjie Weng Xiuqing Qiu

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics